Resultados de la búsqueda 311-320 of 19075 for Two-phase

  1. Oncología (médica) - Ensayos clínicos

    In Part 2 Cohort 1, an expansion phase at the established RP2D will be undertaken in participants with selected advanced solid tumors. In Part 2 Cohort 2, a ...

  2. Oncología (médica) - Ensayos clínicos

    This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...

  3. Oncología (médica) - Ensayos clínicos

    The purpose of part two of this study is to evaluate safety and ... In Part 2 Cohort 2, a safety run in and expansion phase will be undertaken ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Note: Mayo Clinic is only participating in the Phase 2 - Cohort 3 (UPLIFT) portion of the study. Mayo Clinic will not be participating in the QTC sub-study ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Note: Mayo Clinic is only participating in the Phase 2 - Cohort 3 (UPLIFT) portion of the study. Mayo Clinic will not be participating in the QTC sub-study ...

  6. Oncología (médica) - Ensayos clínicos

    Randomized Phase II/III Trial of Adjuvant ... A Study to Compare Two Surgical Procedures in Women With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer.

  7. Dermatología - Ensayos clínicos

    BiCaZO: A Study Combining Two Immunotherapies ... (Stage I and Stage II). Additinoally, to evaluate the ... This phase II trial compares the impact of ...

  8. Obstetricia y Ginecología - Ensayos clínicos

    ... phase 2 dose (RP2D) 1.1.2 To evaluate the safety and tolerability of this combination in a dose expansion cohort in patients with uterine serous carcinoma.

  9. Hematología - Ensayos clínicos - Mayo Clinic

    ... phase 2 dose (RP2D) of APG-2575. In Vivo Assessment of Glutamine Utilization by Bone Marrow Plasma Cells. Rochester, Minn. This study will establish in vivo ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    BiCaZO: A Study Combining Two Immunotherapies ... (Stage I and Stage II). Additinoally, to ... phase 2 dose (RP2D) 1.1.2 To evaluate the safety ...